ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT(6) receptors
- ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT(6) receptors
- Riccioni T; Bordi F; Minetti P; Spadoni G; 윤형문; 임보혜; Tarzia G; 임혜원; Borsini F
- ST1936; Biochemistry; 5-HT6 receptor; cAMP; Fyn kinase; (Rat)
- Issue Date
- European journal of pharmacology
- VOL 661, NO 1-3, 8-14
- 5-HT6 receptor is one of the most recently cloned serotonin receptors, and it might play important roles in
Alzheimer's disease, depression, and learning and memory disorders. Availability of only very few 5-HT6
receptor agonists, however, does not allow examining their contribution in psychopharmacological processes.
Therefore, a new 5-HT6 receptor agonist, ST1936, was synthesized. ST1936 binds to human 5-HT6 receptors
with good affinity (Ki=28.8 nM). ST1936 also exhibited some moderate binding affinity for 5HT2B, 5HT1A,
5HT7 receptors and adrenergic α receptors. ST1936 behaved as a full 5-HT6 agonist on cloned cells and was
able to increase Ca2+ concentration, phosphorylation of Fyn kinase, and regulate the activation of ERK1/2 that
is a downstream target of Fyn kinase. These effects were completely antagonized by two 5-HT6 receptor
antagonists, SB271046 and SB258585. The other 5-HT6 receptor agonist, WAY181187 also increased Fyn
kinase activity. These results suggest that both ST1936 and WAY181187 mediate 5-HT6 receptor-dependent
signal pathways, such as cAMP, Fyn and ERK1/2 kinase, as specific agonists.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.